Cost-Benefit Analysis of Sustained-Release Bupropion, Nicotine Patch, or Both for Smoking Cessation

ISSN： 0091-7435

Source： Preventive Medicine, Vol.30, Iss.3, 2000-03, pp. : 209-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cost-Effectiveness of the Nicotine Transdermal Patch for Smoking Cessation

By Wasley M.A. McNagny S.E. Phillips V.L. Ahluwalia J.S.

Preventive Medicine, Vol. 26, Iss. 2, 1997-03 ,pp. : 264-270

Academic Press

Access to resources Recommend Favorite

The Smoking Cessation Efficacy of Varying Doses of Nicotine Patch Delivery Systems 4 to 5 Years Post-Quit Day

By Daughton D.M. Fortmann S.P. Glover E.D. Hatsukami D.K. Heatley S.A. Lichtenstein E. Repsher L. Millatmal T. Killen J.D. Nowak R.T. Ullrich F. Patil K.D. Rennard S.I.

Preventive Medicine, Vol. 28, Iss. 2, 1999-02 ,pp. : 113-118

Academic Press

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of a Family Physician Delivered Smoking Cessation Program

By Buck D.J. Richmond R.L. Mendelsohn C.P.

Preventive Medicine, Vol. 31, Iss. 6, 2000-12 ,pp. : 641-648

Academic Press

Access to resources Recommend Favorite

A cost-benefit analysis of BCG revaccination in the Czech Republic

By Pathania V.S. Trnka L. Krejbich F. Dye C.

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1926-1935

Elsevier

Access to resources Recommend Favorite

Cost-Effectiveness of the Nicotine Transdermal Patch

By Stapleton J.

Preventive Medicine, Vol. 27, Iss. 2, 1998-02 ,pp. : 304-304

Academic Press

Access to resources Recommend Favorite